Yandex
VC Fund
Moscow, Russian Federation
Yandex is a technological company. They develop products and services by machine learning that include transportation services, navigation products, and mobile applications for consumers. They help consumers and businesses navigate online and offline. Their services use machine learning including in the search results, serving online advertisements, and performing translations.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Yandex invests in
SoftwareE-CommerceHealth CareB2CApps
Stages Yandex invests in
Series ASeries BCorporate RoundGrantFunding Round
Countries Yandex invests in
Russian FederationMoldovaUnited StatesUnited KingdomThe Netherlands
Round sizes
Series A $5M–$6MSeries B $9M–$250MCorporate Round $4M–$325M
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Series A
- $5M–$6M
- Series B
- $9M–$250M
- Corporate Round
- $4M–$325M
Investment Focus
Industry
- Software 2 (20%)
- E-Commerce 2 (20%)
- Health Care 2 (20%)
- B2C 1 (10%)
- Apps 1 (10%)
Stage
- Series A 2 (20%)
- Series B 2 (20%)
- Corporate Round 2 (20%)
- Grant 1 (10%)
- Funding Round 1 (10%)
Country
- Russian Federation 4 (40%)
- Moldova 1 (10%)
- United States 1 (10%)
- United Kingdom 1 (10%)
- The Netherlands 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexei Tretiakov
VP Sales and Business Development Officer
|
VP Sales and Business Development Officer | Total investments: 0 | Find email | |
Anna Veronika Dorogush
Head of Machine Learning Systems & Software Engineer
|
Head of Machine Learning Systems & Software Engineer | Total investments: 1 | Find email | |
|
Anton Abdukhamidov
Corporate development director
|
Corporate development director | Total investments: 1 | Find email | |
Anton Karpov
Chief Information Security Officer
|
Chief Information Security Officer | Total investments: 0 | Find email | |
Dmitry Karmishin
Head Of Sales Operations
|
Head Of Sales Operations | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ClickHouse is an open-source column-oriented database management system that focuses on real-time analytical reporting. It enables users to execute complex SQL queries efficiently, making it suitable for applications that require fast data processing and analysis. The system is particularly effective for big data environments, allowingorganizations to manage and analyze large volumes of information seamlessly. ClickHouse supports various data ingestion methods and offers features that facilitate data warehousing and observability. Its architecture is designed to optimize performance and scalability, catering to the needs of sales teams and data analysts seeking actionable insights from their data. | $250M / Series B / Oct 28, 2021 | ||
| The company delivers genetic tests that help people to live healthier (predisposition tests), save lives (inherited deseases) and help in family planning (carrier screening). | $4M / Corporate Round / Dec 24, 2020 | ||
| Yandex.Market engages in e-commerce, with a core focus on creating a B2C online retail marketplace. | $607.9M / Secondary Market / Jun 25, 2020 | ||
| MEL Science is an educational startup focused to change early science education with a combination of up-to date technologies and hands on experience. Our main products are monthly subscription to chemistry kits and chemistry lessons in VR for schools. | $6M / Series A / Aug 06, 2019 | ||
| DOC+ mission is to make high quality medical service affordable. We started as a pure doctor-house-calls service and transformed into the 1st mobile clinic on the Russian market, providing on-demand doctor house calls, teleconsultations, EHR (electronic health record), medical concierge cervice and more. DOC+ reached 30k customers in 1.5 years andcontinue rapid growth.DOC+ has in its DNA a desire to transform healthcare in Russia. To accomplish it, DOC+ launched an in-home doctor service in August of 2015. Since that, DOC+ has proved the validity of its approach.Developing, DOC+ has smoothly transformed into a mobile clinic in its client's pocket, allowing users to:• Order an in-home visit with one tap of a button• Instantly buy and get delivered prescribed medicineand pills (to be launched in Q2’17)• Get an instant consultation either through a chator by phone• Get a video-consultation (launch in Q1’17)• Keep electronic health records and get instant specialistcomments on issues from blood test results to prescriptions• Get an access to your personal doctor, a database of DOC+verified medical partners with considerable discounts, privilegedservice and free teleconsultations through unique DOC+Caresubscription (monthly / annually)DOC+’s main goal is to offer every medical service that can be done at patient’s home or distantly via telecommunication in a highly personalised way. Our vision is to help DOC+ large customer base get access to the most advanced healthcare technologies, increasing doctor’s utilisation and optimising costs at the same time. We'll do it through further development of telemedical solutions, AI/ML based diagnostics and assistance and personalization. | $9M / Series B / Aug 17, 2018 | ||
| MLU is ride-sharing business of Yandex (NASDAQ: YNDX) and Uber (NYSE: UBER) across Russia and six neighboring countries. Since then it has been operating ride-sharing services in Russia and the CIS under the “Yandex.Taxi” and “Uber” brands. MLU is actively using its technological and operational expertise to expand into international markets. As oftoday, it offers ride-sharing services in 18 countries including in Eastern Europe, Africa and the Middle East. MLU also operates its food delivery service Yandex.Eats and meal kit service Yandex.Chef. | $325M / Corporate Round / Feb 07, 2018 | ||
| DOC+ mission is to make high quality medical service affordable. We started as a pure doctor-house-calls service and transformed into the 1st mobile clinic on the Russian market, providing on-demand doctor house calls, teleconsultations, EHR (electronic health record), medical concierge cervice and more. DOC+ reached 30k customers in 1.5 years andcontinue rapid growth.DOC+ has in its DNA a desire to transform healthcare in Russia. To accomplish it, DOC+ launched an in-home doctor service in August of 2015. Since that, DOC+ has proved the validity of its approach.Developing, DOC+ has smoothly transformed into a mobile clinic in its client's pocket, allowing users to:• Order an in-home visit with one tap of a button• Instantly buy and get delivered prescribed medicineand pills (to be launched in Q2’17)• Get an instant consultation either through a chator by phone• Get a video-consultation (launch in Q1’17)• Keep electronic health records and get instant specialistcomments on issues from blood test results to prescriptions• Get an access to your personal doctor, a database of DOC+verified medical partners with considerable discounts, privilegedservice and free teleconsultations through unique DOC+Caresubscription (monthly / annually)DOC+’s main goal is to offer every medical service that can be done at patient’s home or distantly via telecommunication in a highly personalised way. Our vision is to help DOC+ large customer base get access to the most advanced healthcare technologies, increasing doctor’s utilisation and optimising costs at the same time. We'll do it through further development of telemedical solutions, AI/ML based diagnostics and assistance and personalization. | $5M / Series A / Jun 06, 2017 | ||
| DOC+ mission is to make high quality medical service affordable. We started as a pure doctor-house-calls service and transformed into the 1st mobile clinic on the Russian market, providing on-demand doctor house calls, teleconsultations, EHR (electronic health record), medical concierge cervice and more. DOC+ reached 30k customers in 1.5 years andcontinue rapid growth.DOC+ has in its DNA a desire to transform healthcare in Russia. To accomplish it, DOC+ launched an in-home doctor service in August of 2015. Since that, DOC+ has proved the validity of its approach.Developing, DOC+ has smoothly transformed into a mobile clinic in its client's pocket, allowing users to:• Order an in-home visit with one tap of a button• Instantly buy and get delivered prescribed medicineand pills (to be launched in Q2’17)• Get an instant consultation either through a chator by phone• Get a video-consultation (launch in Q1’17)• Keep electronic health records and get instant specialistcomments on issues from blood test results to prescriptions• Get an access to your personal doctor, a database of DOC+verified medical partners with considerable discounts, privilegedservice and free teleconsultations through unique DOC+Caresubscription (monthly / annually)DOC+’s main goal is to offer every medical service that can be done at patient’s home or distantly via telecommunication in a highly personalised way. Our vision is to help DOC+ large customer base get access to the most advanced healthcare technologies, increasing doctor’s utilisation and optimising costs at the same time. We'll do it through further development of telemedical solutions, AI/ML based diagnostics and assistance and personalization. | $5.5M / Series A / Jul 05, 2016 | ||
| AVO Virtual Roaming Solution is a new generation telecom platform, which provides global mobile coverage for mobile carriers and virtual mobile operators, avoiding classic roaming interconnections with foreign operators or roaming hubs. | $50K / Grant / Jun 01, 2014 | ||
| Sales in the regions of Russia - a "gold mine" of modern e-commerce. | $1M / Jan 29, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
118,083 investors
Software Investors
57,577 investors
Health Care Investors
48,825 investors
Marketplace Investors
48,547 investors
Consumer Investors
38,038 investors
SaaS VC Funds
72,248 investors
Software VC Funds
36,729 investors
Health Care VC Funds
36,610 investors
Marketplace VC Funds
31,693 investors
FAQ
What does Yandex invest in?
Yandex invests primarily in Software, E-Commerce and Health Care startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in Russian Federation. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Yandex invest in?
Yandex typically joins rounds of $5M–$6M at Series A, $9M–$250M at Series B and $4M–$325M at Corporate Round. These are whole funding-round sizes, not Yandex's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Yandex took part in.
How do I contact Yandex?
Public channels for Yandex include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Yandex?
The team at Yandex includes Alexei Tretiakov (VP Sales and Business Development Officer), Anna Veronika Dorogush (Head of Machine Learning Systems & Software Engineer) and Anton Abdukhamidov (Corporate development director), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
